Articles

Fight for Sight, a UK leading eye research charity, has awarded two new grants totalling £350,000 for research into glaucoma ? one of the leading causes of preventable blindness in the UK

In a sample of moderate evaporative-type dry eye disease patients Enriquez-de-Salamanca et al., elevated five inflammatory molecules. Fracktalkine was demonstrated to be present and elevated in tears in human DED.

A new disinfecting technology for soft contact lenses from Abbott has received European regulatory approval. Complete RevitaLens Multipurpose Disinfecting Solution was developed in partnership with the Holden Vision Institute.

This year's highly prestigious Champalimaud Vision Award is shared between two worthy winners for their ground-breaking research in neuroscience and how the brain contructs images.

Carl Zeiss Meditec presented its expanded offering of ophthalmic solutions at this year's WOC 2010 in Berlin.

Optimax has refined its Intralase technology to introduce what it calls 'unprecedented' levels of control for its surgeons through the rollout of the new generation iFS IntraLase Lasers across its UK clinics.

OTE Editorial Advisory Board Member, Professor Gisele Soubrane has become the first woman to receive an International Council of Ophthalmology (ICO) medal.

Retinal imaging company, Optos Plc having made a return to profitability is taking its Optomap Retinal Exam to the ophthalmology community and had a strong presence at this year?s WOC in Berlin.

In his presentation at the World Ophthalmology Congress, Dr Matthew Benz highlighted that the first Phase III trial with microplasmin (TG-MV-006) for the non-surgical treatment of vitreomacular adhesion (VMA) had met its primary endpoint with 27.7% of the 220 microplasmin treated patients achieving resolution of their VMA at 1 month, compared to 13.2% of the 106 patients who received a placebo injection, a highly statistically significant result (p=0.003).

Dr Naveed Shams has been appointed as the new vice president of clinical affairs at Santen Pharmaceutical Co., Ltd.

NCX 434, a new drug candidate form NicOx, is reported to improve oxygen saturation in the eye and preclinical data was recently presented at the Ocular Diseases & Drug Discovery Conference

Developed by US ophthalmologists, the surgical procedure DSAEK (Descemet's Stripping Automated Endothelial Keratoplasty) is increasingly being employed in German eye clinics too.

A team of scientists at UC Irvine (UCI) in California have taken the first step in developing transplant-ready retinas by creating an eight-layer, early-stage retina from human embryonic stem cells.

The European Uveitis Patient Association will present an award to Dr Richard Lee, NIHR clinical lecturer in ophthalmology at the University of Bristol at the forthcoming WOC for his recent research paper

Come and visit the Bausch + Lomb Booth No 16 at the WOC in Berlin to meet the Experts and ask questions. Explore Q2, delivering Quantity and Quality of Vision with the revolutionary Crystalens HD?, the premium accommodating IOL that gives high definition vision at all distances.

Does Google health have a place in practice management

With BluePeak? - blue laser autofluorescence you can noninvasively view the health of the RPE, providing a functional map of RPEphotoreceptor metabolism. BluePeak is available for all SPECTRALIS models.

Haag-Streit and our sister companies – Reliance, Moeller–Wedel, Clement Clarke and John Weiss – are leading players in ophthalmology today – as they have been for more than 150 years.

For nearly two centuries, Moria has been a manufacturer of sophisticated and high quality ophthalmic surgical instrumentation and equipment.

Micro incision surgery for anterior and posterior procedures is featured at the Oertli® booth.

Since introducing the first Laser photocoagulator to ophthalmology in 1970, Lumenis Vision has focused on providing ophthalmologists with innovative laser therapies to preserve and improve the sight of patients worldwide.

According to its press release GBI Research has found that the global ophthalmology market will grow at a moderate rate due to the impact of generic erosion in some markets such as glaucoma and allergic conjunctivitis.

For almost 60 years, the Geuder Group has been developing, manufacturing and distributing ophthalmo-surgical instruments, systems and vitreoretinal liquids.

STAAR Surgical has received CE mark approval for product improvements to its Visian Implantable Collamer Lens (ICL). It also received approval for a Hyperopic Toric ICL which is designed for patients with both hyperopia, as well as astigmatism.

An intact tear film and a good oxygen supply for the cornea are indispensable for contact lens wearing comfort. With the Keratograph TF-Scan software you can analyze the tear film non-invasively.

Experience the revolution in cross linking at booth 15 B 50 where bon Optic will be showing the new Ricrolin TE from the company Sooft.

The Ophthalmology TImes Europe team is looking forward to meeting many readers and customers at the Congress and to bringing you coverage of the event and new developments emerging from it.

Santen is a Japanese R&D focused pharmaceutical company specializing in the development and manufacturing of ophthalmic products.

Recent research by the Optical Express Group says it has revealed that of 32,000 clients surveyed following treatment in 2009, 89 per cent achieved 20/16 vision or better.

According to Novartis the independent DRCR.net study data being presented for the first time in the UK, show that ranibizumab is significantly more effective than laser treatment, the current standard of care, at treating visual impairment due to diabetic macular oedema (DMO).